End-to-End Virtual Screening for Pharma Researchers.

A Quick update: Our Multi-Unimodal Model Paper has been published on ISBI 2025!

Our Paper on our Multi-Unimodal Model architecture has been accepted in the 2025 ISBI conference., and scheduled to be presented in Houston Texas, April 2025!

We hope to see you there! 

Bioforager

End-to-End Virtual Screening for Researchers, Powered by Genesys

Biosentinel

Supporting Biotech Investment Analysts with industry insights

Genesys | Quantu Aware Multi-modal Engine

Genesys is a multi-modal AI model that can predict binding affinity, model trajectories and inference bioactivity

Unified Processing

  • Seamless integration of multiple molecular representations
  • Real-time synchronization of structural and dynamic data
  • Advanced pattern recognition across binding modalities

Adaptive Learning

  • Training on unpaired, asynchronous molecular data
  • Continuous improvement from real-world screening results
  • Flexible adaptation to discovery workflows

Intelligent Scaling

  • More than 50% reduction in computational parameters
  • Superior accuracy with fewer training compounds
  • Seamless integration of new molecular descriptors

Need Support Implementing Deep Learning?

Neuralgap supports custom deep learning builds for Pharma clients.

Interactive image may take a moment to download

Target Identification & Validation

  • AI-driven genomics data analysis
  • Natural language processing for literature mining

Interactive image may take a moment to download

Hit Discovery & Optimization

  • AI-powered virtual screening
  • Structure-based virtual screening using deep learning
  • Machine learning for ADMET prediction
  • Molecular dynamics simulations with GPU acceleration

Interactive image may take a moment to download

Lead Optimization & Candidate Selection

  • Quantitative structure-activity relationship (QSAR) modeling using AI
  • AI-driven toxicity prediction and safety assessment

Our Articles

Follow our weekly article series to keep track of the latest advances in AI in bio and cheminformatics

  • All Posts
  • Biotech
Load More

End of Content.

Get in Touch!

Please enable JavaScript in your browser to complete this form.
Job Title/Role
The work your biotech firm specializes in?
What is the primary challenge you face?